ADC Capacity Updates
-
JOINN Biologics Capacity Update October 2024: ADC
10/21/2024
Leverage our flexible solutions and access to proprietary CHO-K1 cell lines in our state-of-the-art cGMP suites equipped with both single-use and traditional stainless steel bioreactors to support your complex biologics needs.
-
Catalent Capacity Update October 2024: ADC
10/21/2024
Advance ADC development with the SMARTag® Platform, combining precision bioconjugation and a linker-payload library to enhance the therapeutic index and accelerate timelines.
-
AGC Biologics Capacity Update October 2024: ADC
10/21/2024
Streamline your ADC project with the Proveo alliance, offering seamless, end-to-end support across antibody production, bioconjugation, and aseptic fill.
-
Abzena Capacity Update October 2024: ADC
10/21/2024
Leverage our integrated CRO and CDMO services for the development and manufacturing of complex biologics, bioconjugates, and ADCs, ensuring high-quality products and data packages that meet regulatory requirements.